Home

Migraine

Read time: 2 min

Satellite symposium

Migraine preventive therapy—Who is eligible? What are the goals?

Migraine is associated with a substantial economic cost, yet is underdiagnosed and undertreated,...

Read time: 2 min

Satellite symposium

What are the unmet needs and treatment gaps for patients with migraine?

What can be done to improve outcomes for patients with migraine? Patients who have a poor response...

Read time: 3 min

Satellite symposium

What are the barriers to optimal care for patients with migraine?

Understanding the barriers to achieving the best possible care for patients with migraine is key to...

Read time: 2 min

Satellite symposium

Are new migraine preventive therapies meeting unmet needs?

Improved efficacy, tolerability, adherence, and quality of life and lowered total pain burden are...

Read time: 2 min

Congress highlights

Insights into migraine pathology, progression, and treatment

Professor Paul Durham, Missouri State University, speaking during the Hot Topics in Basic Science...

Read time: 3 min

Congress highlights

Does migraine alter COVID-19 susceptibility?

In a late-breaking abstract presentation at #AHSAM21, Professor Robert Shapiro, University of...

Read time: 2 min

Congress highlights

Prevention of medication overuse in clinical practice

Medication overuse occurs in nearly 75% of patients with chronic migraine who are correctly...

Read time: 2 min

Congress highlights

Preventive treatment gaps and priorities in migraine

Speaking at #ASHAM21, Dr Stephanie Nahas, Thomas Jefferson University, identified that only a...

Read time: 2 min

Congress highlights

COVID-19 vaccines, migraine, and preventives: any evidence of interactions?

The advent of COVID-19 vaccines has raised questions on whether vaccines impact on the management...

Read time: 3 min

Congress highlights

Risk and burden of medication-overuse headache among patients with migraine

What is the risk of medication-overuse headache among patients with migraine, including patients...

Read time: 2 min

Congress highlights

CGRP has a role in infection-induced pain

While the role of calcitonin gene-related peptide (CGRP) in headache and migraine is well...

Migraine, Alzheimer's Disease

Read time: 2 min

Congress highlights

Highlights from EAN 2021 — Day 4

Today, 22 June, Day 4 of the 7th Congress of the European Academy of Neurology – Vienna...

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind

You are leaving Progress in Mind

Continue to

Cancel

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intented for health care professionals.

All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline

Congress

Register for access to Progress in Mind in your country